Letter to the Editor

Can ^99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?

Please note: Dr. Berk is a study investigator with Alnylam Pharmaceuticals and Ionis Pharmaceuticals, Inc. Dr. Miller has received a grant from Bracco; and is a consultant and on the steering committee for GE. Dr. Ruberg is supported by NIH awards AG050206 and 1U54TR001012. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.